OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HVAX55

HVAX Technologies Ltd

Advanced Medical Equipment & TechnologyVerified

HVAX Technologies Ltd maintains a debt-to-equity ratio of 0.96, indicating a balanced capital structure with moderate leverage. The company's current ratio of 1.23 suggests it has sufficient short-term assets to cover its short-term liabilities, though the margin is narrow. Despite reporting negative operating cash flow of INR 66.53 million, the company generated positive free cash flow of INR 56.66 million, which may support ongoing operations and reinvestment. The company's financial performance shows mixed signals. While the free cash flow is positive, the negative operating cash flow raises concerns about the sustainability of its core operations. The debt-to-equity ratio of 0.96 is in line with industry norms, but the negative net cash position after subtracting total debt indicates potential liquidity constraints. HVAX Technologies Ltd operates in a single business segment focused on advanced medical equipment and technology. The company's geographic exposure is not disclosed in the available data, making it difficult to assess revenue concentration risks. The company's growth trajectory is uncertain. The available data does not provide specific revenue growth projections for the current or next fiscal year, making it challenging to assess future performance. The company's capital expenditure of INR 5.395 million suggests a modest investment in long-term assets. The risk assessment indicates medium liquidity risk and low dilution risk. The key flag of negative net cash after subtracting total debt highlights potential liquidity constraints. The company's dilution risk is low, as there is no indication of significant share issuance or dilution potential. Recent events and filings do not provide specific details about the company's operations or strategic initiatives. The available data does not include recent transcripts or filings that could provide insight into the company's performance or future plans.

30-day price · HVAX+52.10 (+6.7%)
Low$762.00High$887.95Close$826.45As of17 May, 00:00 UTC
Profile
CompanyHVAX Technologies Ltd
TickerHVAX.NS
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. HVAX Technologies Ltd designs and manufactures advanced medical equipment and technology solutions for healthcare providers and institutions.

Classification. The company is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Advanced Medical Equipment & Technology industry with 92% confidence.

HVAX Technologies Ltd maintains a debt-to-equity ratio of 0.96, indicating a balanced capital structure with moderate leverage. The company's current ratio of 1.23 suggests it has sufficient short-term assets to cover its short-term liabilities, though the margin is narrow. Despite reporting negative operating cash flow of INR 66.53 million, the company generated positive free cash flow of INR 56.66 million, which may support ongoing operations and reinvestment. The company's financial performance shows mixed signals. While the free cash flow is positive, the negative operating cash flow raises concerns about the sustainability of its core operations. The debt-to-equity ratio of 0.96 is in line with industry norms, but the negative net cash position after subtracting total debt indicates potential liquidity constraints. HVAX Technologies Ltd operates in a single business segment focused on advanced medical equipment and technology. The company's geographic exposure is not disclosed in the available data, making it difficult to assess revenue concentration risks. The company's growth trajectory is uncertain. The available data does not provide specific revenue growth projections for the current or next fiscal year, making it challenging to assess future performance. The company's capital expenditure of INR 5.395 million suggests a modest investment in long-term assets. The risk assessment indicates medium liquidity risk and low dilution risk. The key flag of negative net cash after subtracting total debt highlights potential liquidity constraints. The company's dilution risk is low, as there is no indication of significant share issuance or dilution potential. Recent events and filings do not provide specific details about the company's operations or strategic initiatives. The available data does not include recent transcripts or filings that could provide insight into the company's performance or future plans.
Key takeaways
  • HVAX Technologies Ltd maintains a balanced capital structure with a debt-to-equity ratio of 0.96.
  • The company's current ratio of 1.23 indicates it has sufficient short-term assets to cover its short-term liabilities.
  • Despite positive free cash flow, the company reports negative operating cash flow, raising concerns about the sustainability of its core operations.
  • The company's financial performance shows mixed signals, with a debt-to-equity ratio in line with industry norms but a negative net cash position after subtracting total debt.
  • The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data.
  • The risk assessment indicates medium liquidity risk and low dilution risk, with a key flag of negative net cash after subtracting total debt.
  • # RATIONALES
  • {
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow-$66.5M
CapEx-$5.4M
Free cash flow$56.7M
Total assets$910.1M
Total liabilities$685.8M
Total equity$224.4M
Cash & equivalents$35.7M
Long-term debt$214.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$607.5M$47.1M$37.2M$6.0M
FY-3$682.6M$57.0M$41.8M$54.0M
FY-2$959.3M$83.5M$52.0M$61.8M
FY-1$1.06B$127.7M$93.9M$81.0M
FY0$1.31B$170.4M$110.4M$122.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$368.7M$78.2M$28.8M
FY-3$538.7M$120.0M$31.3M
FY-2$782.6M$172.1M$30.1M
FY-1$636.6M$306.0M$11.5M
FY0$1.22B$720.2M$137.2M
PeriodOCFCapExFCFSBC
FY-4$62.9M-$38.3M$6.0M
FY-3-$8.4M$54.0M
FY-2-$36.2M-$927.0k$61.8M
FY-1-$122.4M-$23.7M$81.0M
FY0-$219.4M-$3.2M$122.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$56.7M
FQ-6$468.1M$52.6M$41.6M$24.3M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$910.1M$224.4M$35.7M
FQ-6$636.6M$306.0M$11.5M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7-$66.5M-$5.4M$56.7M
FQ-6-$122.4M-$23.7M$24.3M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$224.4M
Net cash-$179.1M
Current ratio1.2
Debt/Equity1.0
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Advanced Medical Equipment & Technology · cohort 109 companies
MetricHVAXActivity
Op margin-19.9% medp25 -150.5% · p75 8.7%
Net margin-18.4% medp25 -146.8% · p75 8.0%
Gross margin49.9% medp25 36.2% · p75 66.3%
R&D / revenue6.2% medp25 4.7% · p75 12.0%
CapEx / revenue-3.5% medp25 -7.8% · p75 -1.4%
Debt / equity96.0%14.5% medp25 0.9% · p75 54.2%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 00:24 UTC#3ade059e
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 04:03 UTCJob: c6db263d